HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jin-Hee Ahn Selected Research

Estrogens (Estrogen)

6/2012Impact of triple-negative breast cancer phenotype on prognosis in patients with stage I breast cancer.
6/2004Clinical value of cyclooxygenase-2 expression in human breast carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jin-Hee Ahn Research Topics

Disease

73Breast Neoplasms (Breast Cancer)
12/2022 - 06/2004
47Neoplasms (Cancer)
12/2022 - 06/2004
13Renal Cell Carcinoma (Grawitz Tumor)
04/2016 - 10/2010
12Neoplasm Metastasis (Metastasis)
12/2021 - 07/2011
10Sarcoma (Soft Tissue Sarcoma)
01/2022 - 12/2011
9Triple Negative Breast Neoplasms
10/2022 - 07/2011
8Pathologic Complete Response
01/2022 - 06/2012
7Disease Progression
04/2022 - 10/2012
5Stomach Neoplasms (Stomach Cancer)
01/2021 - 08/2002
4Neutropenia
01/2021 - 05/2012
3Pain (Aches)
08/2020 - 01/2019
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2015 - 08/2004
3Residual Neoplasm
06/2015 - 05/2014
2Aggressive Fibromatosis (Desmoid)
10/2022 - 05/2021
2Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 02/2003
2Leiomyosarcoma
01/2022 - 01/2018
2Circulating Neoplastic Cells
03/2021 - 10/2020
2Emergence Delirium
08/2020 - 01/2020
2Hand-Foot Syndrome
01/2019 - 10/2004
2Tertiary Lymphoid Structures
12/2015 - 08/2015
2Adenocarcinoma
10/2015 - 03/2010
2Carcinoma (Carcinomatosis)
08/2015 - 10/2012
2Amenorrhea
09/2013 - 01/2011
2Rectal Neoplasms (Rectal Cancer)
11/2011 - 04/2002
2Brain Neoplasms (Brain Tumor)
07/2011 - 10/2008
2Prostatic Neoplasms (Prostate Cancer)
04/2011 - 03/2010
1Margins of Excision
04/2022
1Interstitial Lung Diseases (Interstitial Lung Disease)
02/2022
1Liposarcoma
01/2022

Drug/Important Bio-Agent (IBA)

18Hormones (Hormone)IBA
04/2022 - 03/2010
15Docetaxel (Taxotere)FDA Link
01/2022 - 10/2004
13Trastuzumab (Herceptin)FDA Link
01/2022 - 04/2012
13AnthracyclinesIBA
01/2019 - 08/2004
11Paclitaxel (Taxol)FDA LinkGeneric
10/2022 - 01/2009
10ErbB Receptors (EGF Receptor)IBA
04/2022 - 08/2004
10Tyrosine Kinase InhibitorsIBA
01/2020 - 01/2012
9Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2015
9GemcitabineFDA Link
01/2022 - 03/2012
9human ERBB2 proteinIBA
08/2021 - 04/2012
8Estrogen ReceptorsIBA
12/2022 - 06/2011
8Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2022 - 02/2005
7EverolimusFDA Link
04/2022 - 12/2013
7taxaneIBA
01/2021 - 08/2004
6Doxorubicin (Adriamycin)FDA LinkGeneric
10/2022 - 01/2009
6Cisplatin (Platino)FDA LinkGeneric
10/2012 - 08/2002
5Carboplatin (JM8)FDA LinkGeneric
10/2022 - 02/2005
5Letrozole (Femara)FDA LinkGeneric
05/2021 - 10/2016
5Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
04/2016 - 04/2012
5Sunitinib (Sutent)FDA Link
09/2013 - 01/2009
4TamoxifenFDA LinkGeneric
04/2021 - 08/2016
4Lapatinib (GW572016)FDA Link
10/2020 - 10/2016
4Epidermal Growth Factor (EGF)IBA
10/2020 - 07/2011
4Vinorelbine (Navelbine)FDA LinkGeneric
12/2019 - 08/2004
4Capecitabine (Xeloda)FDA Link
01/2019 - 08/2004
4Angiogenesis InhibitorsIBA
12/2017 - 01/2014
4Progesterone Receptors (Progesterone Receptor)IBA
10/2014 - 06/2004
3eribulinFDA Link
01/2022 - 11/2017
3pertuzumabIBA
01/2022 - 12/2018
3Proteins (Proteins, Gene)FDA Link
12/2021 - 01/2016
3Phenobarbital (Luminal)FDA Link
12/2021 - 05/2014
3Pharmaceutical PreparationsIBA
01/2019 - 05/2012
3thiamine triphosphorate (TTP)IBA
11/2018 - 08/2014
3orantinib (SU6668)IBA
12/2017 - 08/2014
2Indicators and Reagents (Reagents)IBA
10/2022 - 06/2012
2Leuprolide (Lupron)FDA LinkGeneric
05/2021 - 01/2021
2Alanine Transaminase (SGPT)IBA
01/2021 - 08/2016
2CytokinesIBA
01/2021 - 06/2015
2Zoledronic Acid (Zometa)FDA Link
01/2021 - 01/2011
2Fulvestrant (Faslodex)FDA Link
11/2018 - 06/2011
2DNA (Deoxyribonucleic Acid)IBA
01/2018 - 01/2015
2HLA-A Antigens (HLA-A)IBA
05/2016 - 08/2015
2ParaffinIBA
03/2016 - 06/2004
2Gefitinib (Iressa)FDA Link
10/2015 - 06/2013
2IfosfamideFDA LinkGeneric
12/2013 - 03/2012
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2012 - 01/2012
2Estrogens (Estrogen)FDA Link
06/2012 - 06/2004
2Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
06/2005 - 02/2005
2Fluorouracil (Carac)FDA LinkGeneric
02/2003 - 08/2002
1RNA (Ribonucleic Acid)IBA
10/2022
1Imatinib Mesylate (Gleevec)FDA Link
10/2022
1CateninsIBA
10/2022
1Epirubicin (Ellence)FDA LinkGeneric
10/2022
1pembrolizumabIBA
10/2022
1B7-H1 AntigenIBA
04/2022
1Cyclin-Dependent Kinase 4IBA
04/2022
1trastuzumab deruxtecanIBA
02/2022
1atezolizumabIBA
01/2022

Therapy/Procedure

36Drug Therapy (Chemotherapy)
10/2022 - 04/2002
24Therapeutics
10/2022 - 04/2002
23Neoadjuvant Therapy
10/2022 - 06/2012
13Adjuvant Chemotherapy
01/2022 - 06/2004
12Radiotherapy
04/2022 - 04/2002
6Combination Drug Therapy (Combination Chemotherapy)
11/2017 - 10/2004
3Immunotherapy
01/2022 - 05/2013
3Nephrectomy
05/2013 - 01/2011
2Mastectomy (Mammectomy)
01/2022 - 12/2021
2Anesthesia
08/2020 - 01/2020
2Maintenance Chemotherapy
07/2015 - 05/2013
2Stem Cell Transplantation
06/2005 - 02/2005
1Mammaplasty (Breast Reconstruction)
01/2022